Prilenia
Prilenia is a clinical-stage biotech developing treatments for neurodegenerative and neurodevelopmental disorders, with $106M in funding. Its lead drug candidate, Pridopidine, is in Phase 3 trials for Huntington’s disease and Phase 2/3 trials for ALS. Prilenia’s product is an oral drug candidate targeting neurodegenerative diseases like Huntington’s and ALS. The company focuses on advancing Pridopidine, which has shown promise in movement disorders affecting both adults and children. The company has raised $106M, including a Series B in 2021, and employs 63 people. Its clinical trials are global, with Phase 3 studies underway for Huntington’s disease and Phase 2/3 for ALS.
The growth story
Prilenia grew from 17 to 63 employees between 2021 and 2026, raising $106M along the way, most recently a Series B in November 2021.
About
Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders.Our lead asset is Pridopidine, a first-in-class oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children.Pridopidine is currently being evaluated for the treatment of Huntington’s disease in our global Phase 3 PROOF-HD trial, and for the treatment of ALS in the Phase 2/3 HEALEY platform trial.The company is led by Dr. Michael Hayden, MD, PhD, the founder of five biotech companies and previous President of Global R&D and Chief Scientific Officer at Teva.
Founders and leadership
Prilenia is led by Dr. Michael Hayden, a biotech veteran who founded five companies and previously headed R&D at Teva. Operations is the largest function, with seven employees.
The Prilenia org chart
Dr. Michael Hayden MBChB , PhD (Chief Executive Officer) leads 35 mapped leaders with 5 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Media and Communication 7 (+40% YoY), Legal 7 (+17% YoY), Research 7 (-12% YoY), Operations 7 (0% YoY), Finance 4 (0% YoY), Healthcare Services 3 (0% YoY).
Talent flow
Prilenia’s team draws heavily from Teva Pharmaceuticals, with seven hires, followed by bluebird bio and Amylyx Pharmaceuticals. Alumni have moved to companies like Ovid Therapeutics and Ferrer.
Most common previous employers of Prilenia staff: Teva Pharmaceuticals (7), bluebird bio (4), Amylyx Pharmaceuticals (4), Sanofi (4), Seres Therapeutics (3), Novartis (3). Former Prilenia employees most often moved to Danforth Health (1), DePaul University (1), Ovid Therapeutics (1), Pontera (1), Ferrer (1), FreeOx Biotech (1).
Alumni worth knowing
Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at Prilenia: Project Management (26), Pharmaceutics (21), Leadership (19), Biotechnology (19), Clinical Trials (17), Life Sciences (17), Good Clinical Practice (GCP) (13), Clinical Development (13).
Where the team actually sits
Prilenia people are concentrated in Israel (7), Massachusetts, United States (3), United States (3), Greater Boston (3). 2 offices on record.
Search footprint
Prilenia attracts about 134 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 6 ranking keywords and lost 15 in the last period.
Frequently asked
Prilenia has 63 employees as of September 2026.
Prilenia has raised $106M in total, most recently a Series B round in November 2021.
Dr. Michael Hayden MBChB , PhD (Chief Executive Officer) sits at the top of Prilenia's reporting structure, with 5 direct reports.
The most common previous employers of current Prilenia staff are Teva Pharmaceuticals (7 people), bluebird bio (4 people), Amylyx Pharmaceuticals (4 people).
Former Prilenia employees most often move to Danforth Health (1), DePaul University (1), Ovid Therapeutics (1).
Prilenia attracts about 134 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Prilenia staff are Project Management, Pharmaceutics, Leadership, Biotechnology, Clinical Trials.
Prilenia staff are concentrated in Israel (7), Massachusetts, United States (3), United States (3).
Prilenia has about 7 people in Media and Communication, up 40% over the past year, as of September 2026.
Prilenia has about 7 people in Legal, up 17% over the past year, as of September 2026.
Computed from 43 current and 25 former Prilenia profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.